Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing

Therapeutic targets of CRISPR-Cas can often not be accessed due to lack of carriers to deliver RNPs systematically. Here, the authors engineer modified lipid nanoparticles for delivery of gene editing proteins to specific tissues.

Bibliographic Details
Main Authors: Tuo Wei, Qiang Cheng, Yi-Li Min, Eric N. Olson, Daniel J. Siegwart
Format: Article
Language:English
Published: Nature Portfolio 2020-06-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-020-17029-3
_version_ 1818681694281007104
author Tuo Wei
Qiang Cheng
Yi-Li Min
Eric N. Olson
Daniel J. Siegwart
author_facet Tuo Wei
Qiang Cheng
Yi-Li Min
Eric N. Olson
Daniel J. Siegwart
author_sort Tuo Wei
collection DOAJ
description Therapeutic targets of CRISPR-Cas can often not be accessed due to lack of carriers to deliver RNPs systematically. Here, the authors engineer modified lipid nanoparticles for delivery of gene editing proteins to specific tissues.
first_indexed 2024-12-17T10:07:01Z
format Article
id doaj.art-643f6e049bbd4fa2a9c4925cf329f370
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-12-17T10:07:01Z
publishDate 2020-06-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-643f6e049bbd4fa2a9c4925cf329f3702022-12-21T21:53:08ZengNature PortfolioNature Communications2041-17232020-06-0111111210.1038/s41467-020-17029-3Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editingTuo Wei0Qiang Cheng1Yi-Li Min2Eric N. Olson3Daniel J. Siegwart4Department of Biochemistry, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical CenterDepartment of Biochemistry, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical CenterDepartment of Molecular Biology, Hamon Center for Regenerative Science and Medicine, The University of Texas Southwestern Medical CenterDepartment of Molecular Biology, Hamon Center for Regenerative Science and Medicine, The University of Texas Southwestern Medical CenterDepartment of Biochemistry, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical CenterTherapeutic targets of CRISPR-Cas can often not be accessed due to lack of carriers to deliver RNPs systematically. Here, the authors engineer modified lipid nanoparticles for delivery of gene editing proteins to specific tissues.https://doi.org/10.1038/s41467-020-17029-3
spellingShingle Tuo Wei
Qiang Cheng
Yi-Li Min
Eric N. Olson
Daniel J. Siegwart
Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing
Nature Communications
title Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing
title_full Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing
title_fullStr Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing
title_full_unstemmed Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing
title_short Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing
title_sort systemic nanoparticle delivery of crispr cas9 ribonucleoproteins for effective tissue specific genome editing
url https://doi.org/10.1038/s41467-020-17029-3
work_keys_str_mv AT tuowei systemicnanoparticledeliveryofcrisprcas9ribonucleoproteinsforeffectivetissuespecificgenomeediting
AT qiangcheng systemicnanoparticledeliveryofcrisprcas9ribonucleoproteinsforeffectivetissuespecificgenomeediting
AT yilimin systemicnanoparticledeliveryofcrisprcas9ribonucleoproteinsforeffectivetissuespecificgenomeediting
AT ericnolson systemicnanoparticledeliveryofcrisprcas9ribonucleoproteinsforeffectivetissuespecificgenomeediting
AT danieljsiegwart systemicnanoparticledeliveryofcrisprcas9ribonucleoproteinsforeffectivetissuespecificgenomeediting